All Press Releases
2017, 03, 06 — PILA PHARMA receives regulatory approval of its first clinical trial application and appoints new Chairman of the Board
Malmö, Sweden, 6th March 2017 You can also download the press release as PDF here PILA PHARMA receives regulatory approval of its first clinical trial application and appoints new Chairman of the Board PILA PHARMA AB, a Swedish pharmaceutical company based in Malmö, Sweden, is pleased to announce that it has received regulatory approval of its first clinical trial application thus permitting the…
2016, 06, 22 — Press release / PILA PHARMA successfully completes new shares emission and strengthens the Board of Directors
Malmö, Sweden, 22 June 2016 You can also download the press release as PDF here PILA PHARMA successfully completes new shares emission and strengthens the Board of Directors PILA PHARMA raises new capital to initiate the clinical assessment of XEN-D0501 as novel anti-diabetic agent PILA PHARMA AB, Malmö, Sweden announced today it has completed a successful new shares emission which will…
PILA PHARMA CEO explains potential of “chili receptor” as diabetes therapy
Dr. Dorte Gram, CEO of PILA PHARMA AB, one of Sweden’s youngest biotech companies, talks to Mike Ward, global director of content for Informa Pharma Intelligence’s insights portfolio, about PILA’s history, its novel diabetes technology and why we should keep an eye on its lead asset that will be taking off with clinical studies in the near future. PILA owns…